Cargando…

Should the Optimal Adjuvant Treatment for Patients With Early-Stage Endometrial Cancer With High-Intermediate Risk Factors Depend on Tumor Grade?

OBJECTIVES: To explore whether the optimal adjuvant treatments for patients with early-stage endometrial cancer with high-intermediate risk (HIR) factors should depend on tumor grade. METHODS: A retrospective analysis of patients with HIR endometrial cancer from 1999 to 2012 was conducted. The adjuv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lan, Chunyan, Huang, Xin, Huang, Qidan, Wang, Yin, Gu, Haifeng, Li, Yong, Liu, Jihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Uterine Cancer
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106082/ https://www.ncbi.nlm.nih.gov/pubmed/26397067 http://dx.doi.org/10.1097/IGC.0000000000000572

Ejemplares similares

Possible Risk Factors of Pulmonary Metastases in Patients With International Federation of Gynecology and Obstetrics Stage I Endometrioid-Type Endometrial Cancer
por: Jiang, Wei, et al.
Publicado: (2017)

The Use of Endometrial Cancer Patient–Derived Organoid Culture for Drug Sensitivity Testing Is Feasible
por: Girda, Eugenia, et al.
Publicado: (2017)

Prior Tubal Ligation Might Influence Metastatic Spread of Nonendometrioid Endometrial Carcinoma
por: Li, Mingxia, et al.
Publicado: (2016)

Increased Association Between Endometriosis and Endometrial Cancer: A Nationwide Population-Based Retrospective Cohort Study
por: Yu, Hann-Chin, et al.
Publicado: (2015)

Preoperative Tumor Size at MRI Predicts Deep Myometrial Invasion, Lymph Node Metastases, and Patient Outcome in Endometrial Carcinomas
por: Ytre-Hauge, Sigmund, et al.
Publicado: (2015)

Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
por: Taurin, Sebastien, et al.
Publicado: (2018)

Efficacy and Safety of AEZS-108 (LHRH Agonist Linked to Doxorubicin) in Women With Advanced or Recurrent Endometrial Cancer Expressing LHRH Receptors: A Multicenter Phase 2 Trial (AGO-GYN5)
por: Emons, Günter, et al.
Publicado: (2014)

Fertility Preserved Hysteroscopic Approach for the Treatment of Stage Ia Endometrioid Carcinoma
por: Wang, Fangfang, et al.
Publicado: (2017)

Comparison of Survival Benefits of Combined Chemotherapy and Radiotherapy Versus Chemotherapy Alone for Uterine Serous Carcinoma: A Meta-analysis
por: Lin, Yanying, et al.
Publicado: (2017)

Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer
por: Karim, Safiya, et al.
Publicado: (2019)

Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial Carcinomas
por: Jamieson, Amy, et al.
Publicado: (2023)

Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging
por: Cusimano, Maria C., et al.
Publicado: (2020)

Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study
por: Chen, Jenny Ling-Yu, et al.
Publicado: (2020)

URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer
por: Zhang, Lan, et al.
Publicado: (2014)

Optimal Treatment Strategy in Rectal Cancer Surgery: Should We Be Cowboys or Chickens?
por: Snijders, Heleen S., et al.
Publicado: (2015)

Commentary on: Nomograms based on inflammatory biomarkers for predicting tumor grade and microvascular invasion in stage I/II hepatocellular carcinoma
por: Xiao, Liang, et al.
Publicado: (2019)

Fibroids and Infertility
por: Purohit, P., et al.
Publicado: (2016)

The Role of Complementary and Alternative Medicine for the Management of Fibroids and Associated Symptomatology
por: Dalton-Brewer, Nick
Publicado: (2016)

Natural History of Uterine Fibroids: A Radiological Perspective
por: Ghosh, Srirupa, et al.
Publicado: (2018)

Immunohistochemistry‐Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer
por: Li, Yaqi, et al.
Publicado: (2020)

Survival Outcomes of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer
por: Khalil, Lana, et al.
Publicado: (2022)

Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer
por: Chen, Jenny Ling-Yu, et al.
Publicado: (2021)

The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate‐risk HPV‐negative HNSCC
por: Tasoulas, Jason, et al.
Publicado: (2021)

Optimal resection rate for lung cancer in the UK: how high should we go?
por: Belcher, Elizabeth, et al.
Publicado: (2021)

Adjuvant brachytherapy for Stage IB Grade 2 endometrial carcinoma: Multivariate analysis of a single institution experience
por: Tokar, Margarita, et al.
Publicado: (2016)

Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases
por: McEachron, Jennifer, et al.
Publicado: (2021)

Mismatch repair protein and MLH1 methylation status as predictors of response to adjuvant therapy in endometrial cancer
por: Loukovaara, Mikko, et al.
Publicado: (2021)

The impact of lymph node dissection on survival in patients with clinical early-stage ovarian cancer
por: Deng, Ting, et al.
Publicado: (2021)

The Selection of Time Interval Between Surgery and Adjuvant Therapy in Early Stage Cervical Cancer
por: You, Kai-Yun, et al.
Publicado: (2018)

The histological type of endometrial cancer is not associated with menopause status at diagnosis
por: Sun, Xinyi, et al.
Publicado: (2022)

Adjuvant hormonal therapy for stage I endometrial cancer
por: Gien, L., et al.
Publicado: (2008)

Lymph Node Negative Colorectal Cancers with Isolated Tumor Deposits Should Be Classified and Treated As Stage III
por: Belt, E. J. Th., et al.
Publicado: (2010)

Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma
por: Lin, Han, et al.
Publicado: (2021)

CIP2A protein expression in high-grade, high-stage bladder cancer
por: Huang, Lisa P, et al.
Publicado: (2012)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer
por: Liu, Wenli, et al.
Publicado: (2021)

Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
por: Chen, Shuling, et al.
Publicado: (2019)

Adjuvant chemotherapy for early-stage cervical cancer
por: Asano, Hiroshi, et al.
Publicado: (2016)

Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model
por: Ren, Kang, et al.
Publicado: (2021)

Fertility issue in early stage endometrial cancer patients
por: Topçu, Hasan Onur, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5b7hoe7bo4uqsse7a88udd2r8r